By James Thorne After three years in the IPO desert, VCs look parched. The asset class recorded just $149 billion in exit value in the US...

By Nick Paul Taylor The annual number of medtech acquisitions is on course to slump to its lowest level since 2017, Needham analysts said...

By Susan Kelly Pitchbook analysts are cautiously optimistic that the funding pickup will continue despite uncertainty about interest...

BY JIM HAMMERAND Hologic (NYSE: HOLX) CFO Karleen Oberton had some tough words for ax-dropping executives following recent layoffs in the...

By Nick Paul Taylor Medtech M&A was down for the second straight year after an explosion of deal-making in 2021, with deal volumes down...

By Nick Paul Taylor Supply chain problems, hospital staffing shortages and other challenges that defined 2022 were largely resolved or...

Analysis by Vishal Persaud It's been a pretty brutal year for startups and their founders looking to raise venture capital funding. And...

By Nick Paul Taylor VC investments in medtech startups increased once the initial shock of the pandemic passed. From the third quarter of...

By Nick Paul Taylor Orthopedic companies have made a fast start to 2023, with Zimmer Biomet’s CEO saying “pretty much everything went...

by Julie Coleman CNBC’s Jim Cramer on Monday touted the burgeoning bull market of medical devices, noting positive earnings reports from...

by BioWorld Venture capital comprises 86% of declining med-tech financings in April Med-tech financings have continued to decline from...

WRITTEN BY MEDWORLD ADVISORS As veteran medtech industry executives, we’ve worked on various types of deals throughout our careers,...

By Medical Design & Outsourcing Each company spent more than 15% of their revenue on research. These 10 medtech companies have spent the...

Amanda Pedersen Globus Medical and NuVasive have caused quite the stir in the spine market since announcing merger plans a few weeks...

By Nick Paul Taylor While the number of M&A transactions in the sector last year fell to 46 from 52 in 2021, breaking up deal activity...

By MEDTECHDIVE Medical device companies spent the final three months of 2022 facing many of the same challenges that curbed growth...

By MEDTECHDIVE Companies flush with cash are looking for good investments and innovative products that can reduce procedure costs,...

By HEALTHCAREDIVE Dive Brief: Artificial intelligence could save the U.S. up to $360 billion annually if adopted more widely in...

By MED DEVICE ONLINE Let’s face it. Designing, developing, and bringing a medical device to market takes money — lots of it. While true...

By Medical Device Network Big data and AI attracted attention in 2022, but recession concerns and reimbursement uncertainty may continue...